MATTHEW PETERS: Open Payments
NPI 1043312572 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 30 payments from 11 companies in 2025. Trend: 2023 $697 · 2024 $657 · 2025 $826
Food & beverage: $825Education: $2
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $339 |
| Travere Therapeutics, Inc. | 6 | $101 |
| Mallinckrodt Hospital Products Inc. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Ardelyx, Inc. | 3 | $62 |
| Alexion Pharmaceuticals, Inc. | 2 | $41 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Amgen Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: JYNARQUE, ACTHAR, IBSRELA, FARXIGA, ULTOMIRIS, TARPEYO, TAVNEOS, PREVYMIS.
Industry payments across GA — which companies pay providers there.
